In a market overshadowed by US tariff threats and a tumbling rupee, cautious trading is essential. This article outlines the ...

Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in ...

Recent hiccups related to manufacturing plant issues and tariff uncertainties have led to volatility in earnings and, ...

Aurobindo Pharma's consolidated net profit fell by 10.2% to ₹824 crore in Q1, despite a 4% increase in revenue driven by European and growth market sales.

Brokerage have shared views on multiple stocks today (August 6) post quarterly results. The top stocks that are on the radar of brokerages are: DLF, Adani Ports, Berger Paints, Aurobindo Pharma, ...

Following US President Trump's tariff announcement, Indian pharmaceutical and textile companies experienced significant stock ...

Mumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first ...

Meanwhile, the company's board declared an interim dividend of Rs 4 per share for FY26, The company has fixed 8 August 2025, ...

Alembic Pharmaceuticals reports 14.6% profit rise in Q1, driven by strong U.S. and India sales, launching 4 new products.

Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated ...